BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37349783)

  • 1. Regional vulnerability of brain white matter in vanishing white matter.
    Man JHK; van Gelder CAGH; Breur M; Molenaar D; Abbink T; Altelaar M; Bugiani M; van der Knaap MS
    Acta Neuropathol Commun; 2023 Jun; 11(1):103. PubMed ID: 37349783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical Pathology in Vanishing White Matter.
    Man JHK; van Gelder CAGH; Breur M; Okkes D; Molenaar D; van der Sluis S; Abbink T; Altelaar M; van der Knaap MS; Bugiani M
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic dissection of vanishing white matter pathogenesis.
    Man JHK; Zarekiani P; Mosen P; de Kok M; Debets DO; Breur M; Altelaar M; van der Knaap MS; Bugiani M
    Cell Mol Life Sci; 2024 May; 81(1):234. PubMed ID: 38789799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocyte Subtype Vulnerability in Stem Cell Models of Vanishing White Matter.
    Leferink PS; Dooves S; Hillen AEJ; Watanabe K; Jacobs G; Gasparotto L; Cornelissen-Steijger P; van der Knaap MS; Heine VM
    Ann Neurol; 2019 Nov; 86(5):780-792. PubMed ID: 31433864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanishing white matter: deregulated integrated stress response as therapy target.
    Abbink TEM; Wisse LE; Jaku E; Thiecke MJ; Voltolini-González D; Fritsen H; Bobeldijk S; Ter Braak TJ; Polder E; Postma NL; Bugiani M; Struijs EA; Verheijen M; Straat N; van der Sluis S; Thomas AAM; Molenaar D; van der Knaap MS
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1407-1422. PubMed ID: 31402619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of human stem cell transplantations for Vanishing White Matter: A quest for the Goldilocks graft.
    Hillen AEJ; Leferink PS; Breeuwsma NB; Dooves S; Bergaglio T; Van der Knaap MS; Heine VM
    CNS Neurosci Ther; 2022 Sep; 28(9):1315-1325. PubMed ID: 35778846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocytes are central in the pathomechanisms of vanishing white matter.
    Dooves S; Bugiani M; Postma NL; Polder E; Land N; Horan ST; van Deijk AL; van de Kreeke A; Jacobs G; Vuong C; Klooster J; Kamermans M; Wortel J; Loos M; Wisse LE; Scheper GC; Abbink TE; Heine VM; van der Knaap MS
    J Clin Invest; 2016 Apr; 126(4):1512-24. PubMed ID: 26974157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features of 54 cases of leukoencephalopathy with vanishing white matter disease in children].
    Zhou L; Zhang HH; Chen N; Zhang ZB; Liu M; Dai LF; Wang JM; Jiang YW; Wu Y
    Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):837-843. PubMed ID: 31665837
    [No Abstract]   [Full Text] [Related]  

  • 9. Vanishing white matter: a leukodystrophy due to astrocytic dysfunction.
    Bugiani M; Vuong C; Breur M; van der Knaap MS
    Brain Pathol; 2018 May; 28(3):408-421. PubMed ID: 29740943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Proteome Research in a Zebrafish Model for Vanishing White Matter Disease.
    Kim D; Lee YR; Choi TI; Kim SH; Kang HC; Kim CH; Lee S
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affected astrocytes in the spinal cord of the leukodystrophy vanishing white matter.
    Leferink PS; Breeuwsma N; Bugiani M; van der Knaap MS; Heine VM
    Glia; 2018 Apr; 66(4):862-873. PubMed ID: 29285798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics of cases with leukoencephalopathy with vanishing white matter].
    Wu Y; Jiang YW; Qin J; Xiao JX; Wang JM; Yang YL; Zhang YH; Chang XZ; Lin Q; Wu XR
    Zhonghua Er Ke Za Zhi; 2007 Feb; 45(2):115-20. PubMed ID: 17456339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell Replacement Therapy Improves Pathological Hallmarks in a Mouse Model of Leukodystrophy Vanishing White Matter.
    Dooves S; Leferink PS; Krabbenborg S; Breeuwsma N; Bots S; Hillen AEJ; Jacobs G; van der Knaap MS; Heine VM
    Stem Cell Reports; 2019 Mar; 12(3):441-450. PubMed ID: 30799272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core protocol development for phase 2/3 clinical trials in the leukodystrophy vanishing white matter: a consensus statement by the VWM consortium and patient advocates.
    Schoenmakers DH; Leferink PS; Vanderver A; Bonkowsky JL; Krägeloh-Mann I; Bernard G; Bertini E; Fatemi A; Fogel BL; Wolf NI; Skwirut D; Buck A; Holberg B; Saunier-Vivar EF; Rauner R; Dekker H; van Bokhoven P; Stellingwerff MD; Berkhof J; van der Knaap MS
    BMC Neurol; 2023 Aug; 23(1):305. PubMed ID: 37592248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics-level analysis of myelin formation and regeneration in a mouse model for Vanishing White Matter disease.
    Gat-Viks I; Geiger T; Barbi M; Raini G; Elroy-Stein O
    J Neurochem; 2015 Aug; 134(3):513-26. PubMed ID: 25920008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiological correlates of episodes of acute decline in the leukodystrophy vanishing white matter.
    Stellingwerff MD; van de Wiel MA; van der Knaap MS
    Neuroradiology; 2023 Apr; 65(4):855-863. PubMed ID: 36574026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease.
    Bugiani M; Postma N; Polder E; Dieleman N; Scheffer PG; Sim FJ; van der Knaap MS; Boor I
    Brain; 2013 Jan; 136(Pt 1):209-22. PubMed ID: 23365098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease.
    Shimada S; Shimojima K; Sangu N; Hoshino A; Hachiya Y; Ohto T; Hashi Y; Nishida K; Mitani M; Kinjo S; Tsurusaki Y; Matsumoto N; Morimoto M; Yamamoto T
    Brain Dev; 2015 Nov; 37(10):960-6. PubMed ID: 25843247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult-onset vanishing white matter in a patient with EIF2B3 variants misdiagnosed as multiple sclerosis.
    Xu L; Zhong M; Yang Y; Wang M; An N; Xu X; Zhu Y; Li Z; Chen H; Zhao R; Zheng X
    Neurol Sci; 2022 Apr; 43(4):2659-2667. PubMed ID: 34755279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isocaloric low protein diet in a mouse model for vanishing white matter does not impact ISR deregulation in brain, but reveals ISR deregulation in liver.
    Wisse LE; Visser D; Ter Braak TJ; Bakkali A; Struys EA; Morrison CD; van der Knaap MS; Abbink TEM
    Nutr Neurosci; 2022 Jun; 25(6):1219-1230. PubMed ID: 33236691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.